Skip to content

Development of an Adaptive Treatment for Weight Loss in People With Prediabetes

Development of an Adaptive Treatment Strategy for Weight Loss in People With Prediabetes Using a Sequential Multiple Assignment Randomized Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04745572
Enrollment
90
Registered
2021-02-09
Start date
2021-05-14
Completion date
2023-11-21
Last updated
2025-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, PreDiabetes

Keywords

weight loss, reduced carbohydrate diet, exercise training, time restricted eating

Brief summary

This 16-week study will use an experimental approach called the Sequential Multiple Assignment Randomized Trial to help determine which combination and sequence of weight loss program features are most effective in people who are at risk for type 2 diabetes. Participants in the study will be initially randomized to consume either a high or reduced carbohydrate diet. After 4 weeks, participants will be identified as Responders (greater than or equal to 2.5% weight loss) or Non-Responders (less than 2.5% weight loss). Responders will continue with their initial randomized group for the remainder of the trial. Non-responders will be re-randomized to 2nd stage interventions of either including additional exercise counseling and training or beginning a time restricted eating protocol for the remainder of the trial.

Interventions

Participants randomized to this group will participate in a group-based weight behavioral management program and consume a high carbohydrate (HC) diet. Because this protocol uses a sequential, multiple assignment, randomized trial (SMART) design, response will be assessed at week 4. Responders will continue with their 1st stage assignment for the remainder of the study. Non-responders will be randomized to 2nd stage intervention of either combine HC diet with time-restricted eating (TRE) or HC diet with additional exercise counseling and support.

Participants randomized to this group will participate in a group-based behavioral weight management program and consume a reduced carbohydrate (RC) diet. Because this is a sequential, multiple assignment, randomized trial (SMART) design, response will be assessed at week 4. Responders will continue with their 1st stage assignment for the remainder of the study. Non-responders will be randomized to 2nd stage intervention of either combine RC diet with time-restricted eating (TRE) or RC diet with additional exercise counseling and support.

Sponsors

General Mills
CollaboratorINDUSTRY
University of Alabama at Birmingham
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* 18-75 years of age * BMI of 27 kg/m2 or greater * at risk for developing type 2 diabetes (prediabetes)

Exclusion criteria

* Pregnant, planning to become pregnant, or breastfeeding * uncontrolled hypo or hyperthyroidism

Design outcomes

Primary

MeasureTime frameDescription
Changes in body weightweek 16 visitMeasured on digital scale at final visit.

Secondary

MeasureTime frameDescription
Change in glucoseweek 16 visitSerum glucose will be measured in a fasted state.
Change in hemoglobin A1cweek 16 visitA1c is a measure of average glucose over the previous 3 months.
Change in insulinweek 16 visitSerum insulin will be measured in a fasted state.
Changes in QUICKI indexweek 16 visitPredictor of insulin resistance that will be calculated from glucose and insulin measures

Other

MeasureTime frameDescription
Changes in overall strengthweek 16 visitAs measured by hand grip dynamometry
Changes in fat massweek 16 visitAs measured by bioelectrical impedance analysis (BIA) on the InBody S10 body composition analyzer.
Diet Intake and Physical Activity Monitoringweek 16 visit7-day food logs and weekly physical activity logs
Changes in lipidsweek 16 visitFasting serum concentrations of total cholesterol, HDL cholesterol, triglycerides, and LDL cholesterol
Change in Blood Pressureweek 16 visitMeasured with a clinical grade blood pressure cuff.
Changes in body weightweek 4 visitMeasured on digital scale in order to determine responder or non-responder status.
Changes in aerobic fitnessweek 16 visitAs measured by the 3-minute step test.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026